1246607

Gustavo Fonseca, M.D. — FEI 3030827717

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 16, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Lecanto, FL (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance